Histo-blood group antigens as receptors for rotavirus, new understanding on rotavirus epidemiology and vaccine strategy

References

• Tate JE, Burton AH, Boschi-Pinto Cet al.2008 Estimate of worldwide rotavirus-associated mortality in children younger than 5 years before the introduction of universal rotavirus vaccination programmes: a systematic review and meta-analysis. Lancet Infect Dis 2012;12: 136–141.
   PubMed Web of Science ®Google Scholar
• Parashar UD, Gibson CJ, Bresse JSet al.Rotavirus and severe childhood diarrhea. Emerg Infect Dis 2006;12: 304–306.
   PubMed Web of Science ®Google Scholar
• Walker CL, Rudan I, Liu Let al.Global burden of childhood pneumonia and diarrhoea. Lancet 2013;381: 1405–1416.
   PubMed Web of Science ®Google Scholar
• O'Ryan M.Rotarix (RIX4414): an oral human rotavirus vaccine. Expert Rev Vaccines 2007;6: 11–19.
   PubMed Web of Science ®Google Scholar
• O'Ryan M, Matson DO.New rotavirus vaccines: renewed optimism. J Pediatr 2006;149: 448–451.
   PubMed Web of Science ®Google Scholar
• Ruiz-Palacios GM, Perez-Schael I, Velazquez FRet al.Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med 2006;354: 11–22.
   PubMed Web of Science ®Google Scholar
• Vesikari T, Karvonen AV, Majuri Jet al.Safety, efficacy, and immunogenicity of 2 doses of bovine-human (UK) and rhesus-rhesus-human rotavirus reassortant tetravalent vaccines in Finnish children. J Infect Dis 2006;194: 370–376.
   PubMed Web of Science ®Google Scholar
• Vesikari T, Matson DO, Dennehy Pet al.Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med 2006;354: 23–33.
   PubMed Web of Science ®Google Scholar
• Kang H-Y, Kim KH, Kim JHet al.Economic evaluation of the national immunization program of rotavirus vaccination for children in Korea. Asia Pac J Public Health 2013;25: 145–158.
   PubMed Web of Science ®Google Scholar
• Standaert B, Gomez JA, Raes Met al.Impact of rotavirus vaccination on hospitalisations in Belgium: comparing model predictions with observed data. PLoS One 2013;8: e53864.
   PubMed Web of Science ®Google Scholar
• Tu HAT, Rozenbaum MH, de Boer PTet al.An update of ‘cost-effectiveness of rotavirus vaccination in the Netherlands: the results of a Consensus Rotavirus Vaccine model’. BMC Infect Dis 2013;13: 54.
   PubMed Web of Science ®Google Scholar
• Zlamy M, Kofler S, Orth Det al.The impact of rotavirus mass vaccination on hospitalization rates, nosocomial Rotavirus gastroenteritis and secondary blood stream infections. BMC Infect Dis 2013;13: 112.
   PubMed Web of Science ®Google Scholar
• Wang FT, Mast TC, Glass RJet al.Effectiveness of an incomplete RotaTeq (RV5) vaccination regimen in preventing rotavirus gastroenteritis in the United States. Pediatr Infect Dis J 2013;32: 278–283.
   PubMed Web of Science ®Google Scholar
• Vesikari T, Itzler R, Matson DOet al.Efficacy of a pentavalent rotavirus vaccine in reducing rotavirus-associated health care utilization across three regions (11 countries). Int J Infect Dis 2007;11 (Suppl 2): S29–S35.
   PubMed Web of Science ®Google Scholar
• Yen C, Tate JE, Patel MMet al.Rotavirus vaccines: update on global impact and future priorities. Hum Vaccin 2011;7: 1282–1290.
   PubMed Web of Science ®Google Scholar
• Zaman K, Dang DA, Victor JCet al.Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in Asia: a randomised, double-blind, placebo-controlled trial. Lancet 2010;376: 615–623.
   PubMed Web of Science ®Google Scholar
• Madhi SA, Cunliffe NA, Steele Det al.Effect of human rotavirus vaccine on severe diarrhea in African infants. N Engl J Med 2010;362: 289–298.
   PubMed Web of Science ®Google Scholar
• Armah GE, Sow SO, Breiman RFet al.Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in sub-Saharan Africa: a randomised, double-blind, placebo-controlled trial. Lancet 2010;376: 606–614.
   PubMed Web of Science ®Google Scholar
• Ramani S, Atmar RL, Estes MK.Epidemiology of human noroviruses and updates on vaccine development. Curr Opin Gastroenterol 2014;30: 25–33.
   PubMed Web of Science ®Google Scholar
• Parashar U, Steele D, Neuzil Ket al.Progress with rotavirus vaccines: summary of the Tenth International Rotavirus Symposium. Expert Rev Vaccines 2013;12: 113–117.
   PubMed Web of Science ®Google Scholar
• Clarke E, Desselberger U.Correlates of protection against human rotavirus disease and the factors influencing protection in low-income settings. Mucosal Immunol 2015;8: 1–17.
   PubMed Web of Science ®Google Scholar
• Chilengi R, Simuyandi M, Beach Let al.Association of maternal immunity with rotavirus vaccine immunogenicity in Zambian infants. PLoS One 2016;11: e0150100.
   PubMed Web of Science ®Google Scholar
• Rongsen-Chandola T, Strand TA, Goyal Net al.Effect of withholding breastfeeding on the immune response to a live oral rotavirus vaccine in North Indian infants. Vaccine 2014;32 (Suppl 1): A134–A139.
   PubMed Web of Science ®Google Scholar
• Van Trang N, Vu HT, Le NTet al.Association between norovirus and rotavirus infection and histo-blood group antigen types in Vietnamese children. J Clin Microbiol 2014;52: 1366–1374.
   PubMed Web of Science ®Google Scholar
• Tan M, Jiang X.Histo-blood group antigens: a common niche for norovirus and rotavirus. Expert Rev Mol Med 2014;16: e5.
   PubMed Web of Science ®Google Scholar
• Nordgren J, Sharma S, Bucardo Fet al.Both Lewis and secretor status mediate susceptibility to rotavirus infections in a rotavirus genotype-dependent manner. Clin Infect Dis 2014;59: 1567–1573.
   PubMed Web of Science ®Google Scholar
• Imbert-Marcille B-M, Barbe L, Dupe Met al.A FUT2 gene common polymorphism determines resistance to rotavirus A of the P[8] genotype. J Infect Dis 2014;209: 1227–1230.
   PubMed Web of Science ®Google Scholar
• Hu L, Crawford SE, Czako Ret al.Cell attachment protein VP8* of a human rotavirus specifically interacts with A-type histo-blood group antigen. Nature 2012;485: 256–259.
   PubMed Web of Science ®Google Scholar
• Etzold S, Bode L.Glycan-dependent viral infection in infants and the role of human milk oligosaccharides. Curr Opin Virol 2014;7: 101–107.
   PubMed Web of Science ®Google Scholar
• Rolsma MD, Kuhlenschmidt TB, Gelberg HBet al.Structure and function of a ganglioside receptor for porcine rotavirus. J Virol 1998;72: 9079–9091.
   PubMed Web of Science ®Google Scholar
• Ciarlet M, Ludert JE, Iturriza-Gomara Met al.Initial interaction of rotavirus strains with N-acetylneuraminic (sialic) acid residues on the cell surface correlates with VP4 genotype, not species of origin. J Virol 2002;76: 4087–4095.
   PubMed Web of Science ®Google Scholar
• Ciarlet M, Estes MK.Human and most animal rotavirus strains do not require the presence of sialic acid on the cell surface for efficient infectivity. J Gen Virol 1999;80 (Pt 4): 943–948.
   PubMed Web of Science ®Google Scholar
• Haselhorst T, Fleming FE, Dyason JCet al.Sialic acid dependence in rotavirus host cell invasion. Nat Chem Biol 2009;5: 91–93.
   PubMed Web of Science ®Google Scholar
• Liu Y, Huang P, Tan Met al.Rotavirus VP8*: phylogeny, host range, and interaction with histo-blood group antigens. J Virol 2012;86: 9899–9910.
   PubMed Web of Science ®Google Scholar
• Huang P, Xia M, Tan Met al.Spike protein VP8* of human rotavirus recognizes histo-blood group antigens in a type-specific manner. J Virol 2012;86: 4833–4843.
   PubMed Web of Science ®Google Scholar
• Liu Y, Huang P, Jiang Bet al.Poly-LacNAc as an age-specific ligand for rotavirus P[11] in neonates and infants. PLoS One 2013;8: e78113.
   PubMed Web of Science ®Google Scholar
• Ramani S, Cortes-Penfield NW, Hu Let al.The VP8* domain of neonatal rotavirus strain G10P[11] binds to type II precursor glycans. J Virol 2013;87: 7255–7264.
   PubMed Web of Science ®Google Scholar
• Hu L, Ramani S, Czako Ret al.Structural basis of glycan specificity in neonate-specific bovine-human reassortant rotavirus. Nat Commun 2015;6: 8346.
   PubMed Web of Science ®Google Scholar
• Liu Y, Ramelot TA, Huang Pet al.Glycan specificity of P[19] rotavirus and comparison with those of related P genotypes. J Virol 2016;90: 9983–9996.
   PubMed Web of Science ®Google Scholar
• Payne DC, Parashar UD, Lopman BA.Developments in understanding acquired immunity and innate susceptibility to norovirus and rotavirus gastroenteritis in children. Curr Opin Pediatr 2015;27: 105–109.
   PubMed Web of Science ®Google Scholar
• Nordgren J, Bonkoungou IJO, Nitiema LWet al.Rotavirus in diarrheal children in rural Burkina Faso: high prevalence of genotype G6P[6]. Infect Genet Evol 2012;12: 1892–1898.
   PubMed Web of Science ®Google Scholar
• Sun X, Guo N, Li Jet al.Rotavirus infection and histo-blood group antigens in the children hospitalized with diarrhoea in China. Clin Microbiol Infect 2016;22: 740.e1–3.
   PubMed Web of Science ®Google Scholar
• Marionneau S, Cailleau-Thomas A, Rocher Jet al.ABH and Lewis histo-blood group antigens, a model for the meaning of oligosaccharide diversity in the face of a changing world. Biochimie 2001;83: 565–573.
   PubMed Web of Science ®Google Scholar
• Ruvoen-Clouet N, Ganiere JP, Andre-Fontaine Get al.Binding of rabbit hemorrhagic disease virus to antigens of the ABH histo-blood group family. J Virol 2000;74: 11950–11954.
   PubMed Web of Science ®Google Scholar
• Nordgren J, Nitiema LW, Ouermi Det al.Host genetic factors affect susceptibility to norovirus infections in Burkina Faso. PLoS One 2013;8: e69557.
   PubMed Web of Science ®Google Scholar
• Larsson MM, Rydell GEP, Grahn Aet al.Antibody prevalence and titer to norovirus (genogroup II) correlate with secretor (FUT2) but not with ABO phenotype or Lewis (FUT3) genotype. J Infect Dis 2006;194: 1422–1427.
   PubMed Web of Science ®Google Scholar
• Aguiar DCF, Corvelo TCO, Ara jo Met al.[Expression of ABH and Lewis antigens in chronic gastritis and pre-neoplasic alterations in gastric mucosa]. Expressao dos antigenos ABH e Lewis na gastrite cronica e alteracoes pre- neoplasica da mucosa gastrica. Arq Gastroenterol 2002;39: 222–232.
   PubMedGoogle Scholar
• Tailford LE, Crost EH, Kavanaugh Det al.Mucin glycan foraging in the human gut microbiome. Front Genet 2015;6: 81.
   PubMed Web of Science ®Google Scholar
• Santos N, Hoshino Y.Global distribution of rotavirus serotypes/genotypes and its implication for the development and implementation of an effective rotavirus vaccine. Rev Med Virol 2005;15: 29–56.
   PubMed Web of Science ®Google Scholar
• van Zyl WB, Page NA, Grabow WOet al.Molecular epidemiology of group A rotaviruses in water sources and selected raw vegetables in southern Africa. Appl Environ Microbiol 2006;72: 4554–4560.
   PubMed Web of Science ®Google Scholar
• Steele AD, Ivanoff B.Rotavirus strains circulating in Africa during 1996-1999: emergence of G9 strains and P[6] strains. Vaccine 2003;21: 361–367.
   PubMed Web of Science ®Google Scholar
• Seheri LM, Page N, Dewar JBet al.Characterization and molecular epidemiology of rotavirus strains recovered in Northern Pretoria, South Africa during 2003-2006. J Infect Dis 2010;202 (Suppl): S139–S147.
   PubMed Web of Science ®Google Scholar
• Todd S, Page NA, Duncan Steele Aet al.Rotavirus strain types circulating in Africa: review of studies published during 1997-2006. J Infect Dis 2010;202 (Suppl): S34–S42.
   PubMed Web of Science ®Google Scholar
• Pager CT, Alexander JJ, Steele AD.South African G4P[6] asymptomatic and symptomatic neonatal rotavirus strains differ in their NSP4, VP8*, and VP7 genes. J Med Virol 2000;62: 208–216.
   PubMed Web of Science ®Google Scholar
• Mascarenhas JD, Linhares AC, Bayma APet al.Molecular analysis of VP4, VP7, and NSP4 genes of P[6]G2 rotavirus genotype strains recovered from neonates admitted to hospital in Belem, Brazil. J Med Virol 2006;78: 281–289.
   PubMed Web of Science ®Google Scholar
• Santos N, Volotao EM, Soares CCet al.Rotavirus strains bearing genotype G9 or P[9] recovered from Brazilian children with diarrhea from 1997 to 1999. J Clin Microbiol 2001;39: 1157–1160.
   PubMed Web of Science ®Google Scholar
• Santos N, Soares CC, Volotao EMet al.Surveillance of rotavirus strains in Rio de Janeiro, Brazil, from 1997 to 1999. J Clin Microbiol 2003;41: 3399–3402.
   PubMed Web of Science ®Google Scholar
• Khananurak K, Vutithanachot V, Simakachorn Net al.Prevalence and phylogenetic analysis of rotavirus genotypes in Thailand between 2007 and 2009. Infect Genet Evol 2010;10: 537–545.
   PubMed Web of Science ®Google Scholar
• De Grazia S, Ramirez S, Giammanco GMet al.Diversity of human rotaviruses detected in Sicily, Italy, over a 5-year period (2001-2005). Arch Virol 2007;152: 833–837.
   PubMed Web of Science ®Google Scholar
• Banyai K, Bogdan A, Domonkos Get al.Genetic diversity and zoonotic potential of human rotavirus strains, 2003-2006, Hungary. J Med Virol 2009;81: 362–370.
   PubMed Web of Science ®Google Scholar
• Gazal S, Taku AK, Kumar B.Predominance of rotavirus genotype G6P[11] in diarrhoeic lambs. Vet J 2012;193: 299–300.
   PubMed Web of Science ®Google Scholar
• Iturriza Gomara M, Kang G, Mammen Aet al.Characterization of G10P[11] rotaviruses causing acute gastroenteritis in neonates and infants in Vellore, India. J Clin Microbiol 2004;42: 2541–2547.
   PubMed Web of Science ®Google Scholar
• Libonati MH, Dennis AF, Ramani Set al.Absence of genetic differences among G10P[11] rotaviruses associated with asymptomatic and symptomatic neonatal infections in Vellore, India. J Virol 2014;88: 9060–9071.
   PubMed Web of Science ®Google Scholar
• Yu Y, Lasanajak Y, Song Xet al.Human milk contains novel glycans that are potential decoy receptors for neonatal rotaviruses. Mol Cell Proteomics 2014;13: 2944–2960.
   PubMed Web of Science ®Google Scholar
• Karlsson KA, Larson G.Molecular characterization of cell-surface antigens of human fetal tissue: meconium, a rich source of epithelial blood-group glycolipids. FEBS Lett 1978;87: 283–287.
   PubMed Web of Science ®Google Scholar
• Trabelsi A, Peenze I, Pager Cet al.Distribution of rotavirus VP7 serotypes and VP4 genotypes circulating in Sousse, Tunisia, from 1995 to 1999: emergence of natural human reassortants. J Clin Microbiol 2000;38: 3415–3419.
   PubMed Web of Science ®Google Scholar
• Potgieter N, de Beer MC, Taylor MBet al.Prevalence and diversity of rotavirus strains in children with acute diarrhea from rural communities in the Limpopo Province, South Africa, from 1998 to 2000. J Infect Dis 2010;202 (Suppl): S148–S155.
   PubMed Web of Science ®Google Scholar
• Mwenda JM, Ntoto KM, Abebe Aet al.Burden and epidemiology of rotavirus diarrhea in selected African countries: preliminary results from the African Rotavirus Surveillance Network. J Infect Dis 2010;202 (Suppl): S5–S11.
   PubMed Web of Science ®Google Scholar
• Ramani S, Sowmyanarayanan TV, Gladstone BPet al.Rotavirus infection in the neonatal nurseries of a tertiary care hospital in India. Pediatr Infect Dis J 2008;27: 719–723.
   PubMed Web of Science ®Google Scholar
• Malik YS, Sharma K, Vaid Net al.Frequency of group A rotavirus with mixed G and P genotypes in bovines: predominance of G3 genotype and its emergence in combination with G8/G10 types. J Vet Sci 2012;13: 271–278.
   PubMed Web of Science ®Google Scholar
• Broor S, Ghosh D, Mathur P.Molecular epidemiology of rotaviruses in India. Indian J Med Res 2003;118: 59–67.
   PubMed Web of Science ®Google Scholar
• Xia L-L, He B, Hu T-Set al.[Isolation and characterization of rotavirus from bat]. Bing Du Xue Bao 2013;29: 632–637.
   PubMedGoogle Scholar
• Hurd EA, Domino SE.Increased susceptibility of secretor factor gene Fut2-null mice to experimental vaginal candidiasis. Infect Immun 2004;72: 4279–4281.
   PubMed Web of Science ®Google Scholar
• Amimo JO, Junga JO, Ogara WOet al.Detection and genetic characterization of porcine group A rotaviruses in asymptomatic pigs in smallholder farms in East Africa: predominance of P[8] genotype resembling human strains. Vet Microbiol 2015;175: 195–210.
   PubMed Web of Science ®Google Scholar
• Chandler-Bostock R, Hancox LR, Nawaz Set al.Genetic diversity of porcine group A rotavirus strains in the UK. Vet Microbiol 2014;173: 27–37.
   PubMed Web of Science ®Google Scholar
• Halaihel N, Masia RM, Fernandez-Jimenez Met al.Enteric calicivirus and rotavirus infections in domestic pigs. Epidemiol Infect 2010;138: 542–548.
   PubMed Web of Science ®Google Scholar
• Simmonds MK, Armah G, Asmah Ret al.New oligonucleotide primers for P-typing of rotavirus strains: Strategies for typing previously untypeable strains. J Clin Virol 2008;42: 368–373.
   PubMed Web of Science ®Google Scholar
• Benhafid M, Youbi M, Klena JDet al.Epidemiology of rotavirus gastroenteritis among children <5 years of age in Morocco during 1 year of sentinel hospital surveillance, June 2006-May 2007. J Infect Dis 2009;200 (Suppl 1): S70–S75.
   PubMed Web of Science ®Google Scholar
• Solberg OD, Hasing ME, Trueba Get al.Characterization of novel VP7, VP4, and VP6 genotypes of a previously untypeable group A rotavirus. Virology 2009;385: 58–67.
   PubMed Web of Science ®Google Scholar
• Soeorg H, Tamm E, Huik Ket al.Group A rotavirus genotypes circulating prior to implementation of a National Immunization Program in Estonia. Hum Vaccin Immunother 2012;8: 465–469.
   PubMed Web of Science ®Google Scholar
• Moussa A, Ben Hadj Fredj M, Fodha Iet al.Distribution of rotavirus VP7 and VP4 genotypes circulating in Tunisia from 2009 to 2014: emergence of the genotype G12. J Med Microbiol 2016;65: 1028–1037.
   PubMed Web of Science ®Google Scholar
• Huang P, Xia M, Tan Met al.Spike protein VP8* of human rotavirus recognizes histo-blood group antigens in a type-specific manner. J Virol 2012;86: 4833–4843.
   PubMed Web of Science ®Google Scholar
• Liu Y, Huang P, Tan Met al.Rotavirus VP8*: phylogeny, host range, and interaction with histo-blood group antigens. J Virol 2012;86: 9899–9910.
   PubMed Web of Science ®Google Scholar
• Ward RL, McNeal MM, Sander DSet al.Immunodominance of the VP4 neutralization protein of rotavirus in protective natural infections of young children. J Virol 1993;67: 464–468.
   PubMed Web of Science ®Google Scholar
• Ward RL, Knowlton DR, Schiff GMet al.Relative concentrations of serum neutralizing antibody to VP3 and VP7 proteins in adults infected with a human rotavirus. J Virol 1988;62: 1543–1549.
   PubMed Web of Science ®Google Scholar
• Hsieh Y-C, Wu F-T, Hsiung CAet al.Comparison of virus shedding after lived attenuated and pentavalent reassortant rotavirus vaccine. Vaccine 2014;32: 1199–1204.
   PubMed Web of Science ®Google Scholar
• Bernstein DI, Smith VE, Sander DSet al.Evaluation of WC3 rotavirus vaccine and correlates of protection in healthy infants. J Infect Dis 1990;162: 1055–1062.
   PubMed Web of Science ®Google Scholar
• Clark HF, Borian FE, Bell LMet al.Protective effect of WC3 vaccine against rotavirus diarrhea in infants during a predominantly serotype 1 rotavirus season. J Infect Dis 1988;158: 570–587.
   PubMed Web of Science ®Google Scholar
• Clark HF, Offit PA, Ellis RWet al.WC3 reassortant vaccines in children. Arch Virol 1996;12: 187–198.
   Google Scholar
• Heaton PM, Ciarlet M.Vaccines: the pentavalent rotavirus vaccine: discovery to licensure and beyond. Clin Infect Dis 2007;45: 1618–1624.
   PubMed Web of Science ®Google Scholar
• Paul A, Babji S, Sowmyanarayanan TVet al.Human and bovine rotavirus strain antigens for evaluation of immunogenicity in a randomized, double-blind, placebo-controlled trial of a single dose live attenuated tetravalent, bovine-human-reassortant, oral rotavirus vaccine in Indian adults. Vaccine 2014;32: 3094–3100.
   PubMed Web of Science ®Google Scholar
• Goveia MG, Ciarlet M, Owen KEet al.Development, clinical evaluation, and post-licensure impact of RotaTeq, a pentavalent rotavirus vaccine. Ann NY Acad Sci 2011;1222: 14–18.
   PubMed Web of Science ®Google Scholar
• Wyatt RG, Mebus CA, Yolken RHet al.Rotaviral immunity in gnotobiotic calves: heterologous resistance to human virus induced by bovine virus. Science 1979;203: 548–550.
   PubMed Web of Science ®Google Scholar
• Matthijnssens J, Joelsson DB, Warakomski DJet al.Molecular and biological characterization of the 5 human-bovine rotavirus (WC3)-based reassortant strains of the pentavalent rotavirus vaccine, RotaTeq. Virology 2010;403: 111–127.
   PubMed Web of Science ®Google Scholar
• Luna EJA, Frazatti-Gallina NM, Timenetsky MCSTet al.A phase I clinical trial of a new 5-valent rotavirus vaccine. Vaccine 2013;31: 1100–1105.
   PubMed Web of Science ®Google Scholar
• Zade JK, Kulkarni PS, Desai SAet al.Bovine rotavirus pentavalent vaccine development in India. Vaccine 2014;32 (Suppl 1): A124–A128.
   PubMed Web of Science ®Google Scholar
• Than VT, Jeong S, Kim W.Characterization of RotaTeq vaccine-derived rotaviruses in South Korean infants with rotavirus gastroenteritis. J Med Virol 2015;87: 112–116.
   PubMed Web of Science ®Google Scholar
• Heylen E, Zeller M, Ciarlet Met al.Comparative analysis of pentavalent rotavirus vaccine strains and G8 rotaviruses identified during vaccine trial in Africa. Sci Rep 2015;5: 14658.
   PubMed Web of Science ®Google Scholar
• Tapia MD, Armah G, Breiman RFet al.Secondary efficacy endpoints of the pentavalent rotavirus vaccine against gastroenteritis in sub-Saharan Africa. Vaccine 2012;30 (Suppl 1): A79–A85.
   PubMed Web of Science ®Google Scholar
• Jiang B, Gentsch JR, Glass RI.Inactivated rotavirus vaccines: A priority for accelerated vaccine development. Vaccine 2008;26: 6754–6758.
   PubMed Web of Science ®Google Scholar
• Wang Y, Azevedo M, Saif LJet al.Inactivated rotavirus vaccine induces protective immunity in gnotobiotic piglets. Vaccine 2010;28: 5432–5436.
   PubMed Web of Science ®Google Scholar
• Jiang B, Wang Y, Glass RI.Does a monovalent inactivated human rotavirus vaccine induce heterotypic immunity? Evidence from animal studies. Hum Vaccin Immunother 2013;9: 1634–1637.
   PubMed Web of Science ®Google Scholar
• Azevedo MP, Vlasova AN, Saif LJ.Human rotavirus virus-like particle vaccines evaluated in a neonatal gnotobiotic pig model of human rotavirus disease. Expert Rev Vaccines 2013;12: 169–181.
   PubMed Web of Science ®Google Scholar
• Wen X, Cao D, Jones RWet al.Construction and characterization of human rotavirus recombinant VP8* subunit parenteral vaccine candidates. Vaccine 2012;30: 6121–6126.
   PubMed Web of Science ®Google Scholar
• Xue M, Yu L, Che Yet al.Characterization and protective efficacy in an animal model of a novel truncated rotavirus VP8 subunit parenteral vaccine candidate. Vaccine 2015;33: 2606–2613.
   PubMed Web of Science ®Google Scholar
• Wen X, Wen K, Cao Det al.Inclusion of a universal tetanus toxoid CD4(+) T cell epitope P2 significantly enhanced the immunogenicity of recombinant rotavirus DeltaVP8* subunit parenteral vaccines. Vaccine 2014;32: 4420–4427.
   PubMed Web of Science ®Google Scholar
• Tan M, Jiang X.Subviral particle as vaccine and vaccine platform. Curr Opin Virol 2014;6: 24–33.
   PubMed Web of Science ®Google Scholar
• Tan M, Fang P, Chachiyo Tet al.Noroviral P particle: structure, function and applications in virus-host interaction. Virology 2008;382: 115–123.
   PubMed Web of Science ®Google Scholar
• Tan M, Jiang X.The p domain of norovirus capsid protein forms a subviral particle that binds to histo-blood group antigen receptors. J Virol 2005;79: 14017–14030.
   PubMed Web of Science ®Google Scholar
• Tan M, Xia M, Huang Pet al.Norovirus P particle as a platform for antigen presentation. Procedia Vaccinol 2011;4: 19–26.
   Google Scholar
• Tan M, Huang P, Xia Met al.Norovirus P particle, a novel platform for vaccine development and antibody production. J Virol 2011;85: 753–764.
   PubMed Web of Science ®Google Scholar
• Tan M, Jiang X.Norovirus P particle: a subviral nanoparticle for vaccine development against norovirus, rotavirus and influenza virus. Nanomedicine 2012;7: 889–897.
   PubMed Web of Science ®Google Scholar
• Tan M, Jiang X.Recent advancements in combination subunit vaccine development. Hum Vaccin Immunother 2016;13: 180–185.
   Web of Science ®Google Scholar
• Wang L, Huang P, Fang Het al.Polyvalent complexes for vaccine development. Biomaterials 2013;34: 4480–4492.
   PubMed Web of Science ®Google Scholar
• Wang L, Xia M, Huang Pet al.Branched-linear and agglomerate protein polymers as vaccine platforms. Biomaterials 2014;35: 8427–8438.
   PubMed Web of Science ®Google Scholar
• Xia M, Wei C, Wang Let al.Development and evaluation of two subunit vaccine candidates containing antigens of hepatitis E virus, rotavirus, and astrovirus. Sci Rep 2016;6: 25735.
   PubMed Web of Science ®Google Scholar